logo Enovis.jpg
Enovis Announces Third Quarter 2023 Results and Raises Full-Year Outlook
November 07, 2023 06:00 ET | Enovis Corporation
Continued strong momentum with third quarter sales growth of 9% and strong adjusted EBITDA margin expansionOrganic growth of 10% in Recon and 4% in P&RReported a third quarter net loss...
SU-2206-ARVIS2.0-PRD-HEADSET3_4 LEFT_ON BODY
Enovis™ to Showcase New Surgical Innovations at AAHKS Annual Meeting
October 30, 2023 08:00 ET | Enovis Corporation
Wilmington, DE, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, announced it will showcase the latest technologies from...
logo Enovis.jpg
ENOVIS CORPORATION ANNOUNCES PRICING OF PRIVATE OFFERING OF $400 MILLION OF 3.875% CONVERTIBLE SENIOR NOTES DUE 2028
October 20, 2023 06:00 ET | Enovis Corporation
Wilmington, DE, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today announced the pricing of $400 million aggregate principal amount of 3.875%...
logo Enovis.jpg
Enovis Corporation Releases Preliminary Information About Its Performance for the Third Quarter 2023
October 19, 2023 06:58 ET | Enovis Corporation
Wilmington, DE, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today released the following preliminary information about its performance for the third...
logo Enovis.jpg
Enovis Corporation Announces Proposed Private Offering of $400 Million of Convertible Senior Notes
October 19, 2023 06:51 ET | Enovis Corporation
Wilmington, DE, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today announced its intention to offer, subject to market conditions and other factors,...
logo Enovis.jpg
Enovis to Host Third Quarter 2023 Results Conference Call on November 7th
October 16, 2023 07:00 ET | Enovis Corporation
Wilmington, DE, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will host an investor conference...
logo Enovis.jpg
Enovis to Acquire LimaCorporate S.p.A.
September 25, 2023 06:00 ET | Enovis Corporation
Creating a high-growth, global reconstruction leader with ~$1 billion in annual revenueAttractive margin profile and meaningful synergies expected to increase profitability Wilmington, DE,...
AOFAS 2023 PR Image
Enovis Debuts New Foot & Ankle Offerings at the AOFAS Annual Meeting
September 18, 2023 08:30 ET | Enovis Corporation
Wilmington, DE, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, announced it will showcase new products from its recent...
logo Enovis.jpg
Enovis to Participate in Upcoming Investor Conferences
August 08, 2023 08:24 ET | Enovis Corporation
Wilmington, DE, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate...
logo Enovis.jpg
Enovis Announces Second Quarter 2023 Results and Raises Full-Year Outlook
August 03, 2023 06:00 ET | Enovis Corporation
Continued strong momentum with second quarter sales growth of 8% and strong EBITDA margin expansionOrganic growth of 17% in Recon and 4% in P&R Reported a second quarter net loss from...